Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
With the slowdown in world economic growth, the Antiretroviral Drug industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Antiretroviral Drug market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Antiretroviral Drug market size will be further expanded, we expect that by 2023, The market size of the Antiretroviral Drug will reach XXX million $.
Antiretroviral drugs are medications used for the treatment of infection caused due to retroviruses, a type of virus in the viral family of Retroviridae. Human immunodeficiency virus (HIV), human T-lymphotropic virus type 1 (HTLV-1), and human T-lymphotropic virus type 2 (HTLV-II) are some of the major retroviruses that cause diseases in humans. Antiretroviral drugs regulate the growth of retroviruses.
High prevalence of HIV/AIDS is expected propel growth of the global antiretroviral drugs market over the forecast period. For instance, according to UNAIDS Global HIV & AIDS statistics — 2019 fact sheet, 37.9 million people were infected with HIV worldwide. Moreover, increasing adoption of antiretroviral drugs is also expected to aid in growth of the market. For instance, according to UNAIDS Global HIV & AIDS statistics — 2019 fact sheet, around 24.5 million people were accessing antiretroviral therapy.
Improved availability of HIV testing services in emerging economies is expected to offer lucrative growth opportunities for players in the global antiretroviral drugs market. For instance, according to UNAIDS, 85% of people living with HIV worldwide were aware of their status, in 2018. Moreover, increasing adoption of antiretroviral treatment in emerging economies is also expected to aid in growth of the market. For instance, according to UNAIDS, around 13.8 million people adopted antiretroviral treatment in East and Southern Africa in 2018, accounting for over three-fold increase from 2010 numbers.
The adoption of antiretroviral drugs among HIV-infected pregnant woman is on the rise. For instance, according to UNAIDS, around 82% of pregnant women living with HIV had access to antiretroviral drugs to prevent transmission of HIV to their child in 2018. The market is also witnessing R&D in combination therapy for the treatment of retroviral infections. For instance, Viriom Inc.’s orally available prodrug of VM1500A can be used with other antiretroviral drugs for the treatment of HIV1 infection.
Emerging economies are witnessing increasing funding for the treatment and management of HIV/AIDS. According to UNAIDS, domestic and international resources for HIV responses in East and Southern Africa increased by 34% and 31% respectively, between 2010 and 2018.
Key Takeaways
- High prevalence of HIV/AIDS to augment growth of the global antiretroviral drugs market over the forecast period
- Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, ViiV Healthcare renewed its partnership with the University of North Carolina at Chapel Hill focused on discovering a cure for HIV.
- Major players operating in the global antiretroviral drugs market include, Gilead Sciences, ViiV Healthcare, Bristol-Myer Squibb, Mylan N.V., AbbVie, Boehringer-Ingelheim, Johnson and Johnson, Merck, and Cipla Limited
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Industry Segmentation
Hospital
Pharmaceutical Companies
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2018-2023)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Table of Contents
Section 1 Antiretroviral Drug Product Definition
Section 2 Global Antiretroviral Drug Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Antiretroviral Drug Shipments
2.2 Global Manufacturer Antiretroviral Drug Business Revenue
2.3 Global Antiretroviral Drug Market Overview
Section 3 Manufacturer Antiretroviral Drug Business Introduction
3.1 Gilead Sciences Antiretroviral Drug Business Introduction
3.1.1 Gilead Sciences Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
3.1.2 Gilead Sciences Antiretroviral Drug Business Distribution by Region
3.1.3 Gilead Sciences Interview Record
3.1.4 Gilead Sciences Antiretroviral Drug Business Profile
3.1.5 Gilead Sciences Antiretroviral Drug Product Specification
3.2 ViiV Healthcare Antiretroviral Drug Business Introduction
3.2.1 ViiV Healthcare Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
3.2.2 ViiV Healthcare Antiretroviral Drug Business Distribution by Region
3.2.3 Interview Record
3.2.4 ViiV Healthcare Antiretroviral Drug Business Overview
3.2.5 ViiV Healthcare Antiretroviral Drug Product Specification
3.3 Bristol-Myer Squibb Antiretroviral Drug Business Introduction
3.3.1 Bristol-Myer Squibb Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
3.3.2 Bristol-Myer Squibb Antiretroviral Drug Business Distribution by Region
3.3.3 Interview Record
3.3.4 Bristol-Myer Squibb Antiretroviral Drug Business Overview
3.3.5 Bristol-Myer Squibb Antiretroviral Drug Product Specification
3.4 AbbVie Antiretroviral Drug Business Introduction
3.5 Boehringer-Ingelheim Antiretroviral Drug Business Introduction
3.6 Johnson and Johnson Antiretroviral Drug Business Introduction
…
Section 4 Global Antiretroviral Drug Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.1.2 Canada Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.2 South America Country
4.2.1 South America Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.3 Asia Country
4.3.1 China Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.3.2 Japan Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.3.3 India Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.3.4 Korea Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.4 Europe Country
4.4.1 Germany Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.4.2 UK Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.4.3 France Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.4.4 Italy Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.4.5 Europe Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.5 Other Country and Region
4.5.1 Middle East Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.5.2 Africa Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.5.3 GCC Antiretroviral Drug Market Size and Price Analysis 2014-2018
4.6 Global Antiretroviral Drug Market Segmentation (Region Level) Analysis 2014-2018
4.7 Global Antiretroviral Drug Market Segmentation (Region Level) Analysis
Section 5 Global Antiretroviral Drug Market Segmentation (Product Type Level)
5.1 Global Antiretroviral Drug Market Segmentation (Product Type Level) Market Size 2014-2018
5.2 Different Antiretroviral Drug Product Type Price 2014-2018
5.3 Global Antiretroviral Drug Market Segmentation (Product Type Level) Analysis
Section 6 Global Antiretroviral Drug Market Segmentation (Industry Level)
6.1 Global Antiretroviral Drug Market Segmentation (Industry Level) Market Size 2014-2018
6.2 Different Industry Price 2014-2018
6.3 Global Antiretroviral Drug Market Segmentation (Industry Level) Analysis
Section 7 Global Antiretroviral Drug Market Segmentation (Channel Level)
7.1 Global Antiretroviral Drug Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
7.2 Global Antiretroviral Drug Market Segmentation (Channel Level) Analysis
Section 8 Antiretroviral Drug Market Forecast 2018-2023
8.1 Antiretroviral Drug Segmentation Market Forecast (Region Level)
8.2 Antiretroviral Drug Segmentation Market Forecast (Product Type Level)
8.3 Antiretroviral Drug Segmentation Market Forecast (Industry Level)
8.4 Antiretroviral Drug Segmentation Market Forecast (Channel Level)
Section 9 Antiretroviral Drug Segmentation Product Type
9.1 Multi-Class Drugs Combination Product Introduction
9.2 NRTI Product Introduction
9.3 NNRTI Product Introduction
9.4 Protease Inhibitors Product Introduction
Section 10 Antiretroviral Drug Segmentation Industry
10.1 Hospital Clients
10.2 Pharmaceutical Companies Clients
Section 11 Antiretroviral Drug Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Antiretroviral Drug Product Picture from Gilead Sciences
Chart 2014-2018 Global Manufacturer Antiretroviral Drug Shipments (Units)
Chart 2014-2018 Global Manufacturer Antiretroviral Drug Shipments Share
Chart 2014-2018 Global Manufacturer Antiretroviral Drug Business Revenue (Million USD)
Chart 2014-2018 Global Manufacturer Antiretroviral Drug Business Revenue Share
Chart Gilead Sciences Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
Chart Gilead Sciences Antiretroviral Drug Business Distribution
Chart Gilead Sciences Interview Record (Partly)
Figure Gilead Sciences Antiretroviral Drug Product Picture
Chart Gilead Sciences Antiretroviral Drug Business Profile
Table Gilead Sciences Antiretroviral Drug Product Specification
Chart ViiV Healthcare Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
Chart ViiV Healthcare Antiretroviral Drug Business Distribution
Chart ViiV Healthcare Interview Record (Partly)
Figure ViiV Healthcare Antiretroviral Drug Product Picture
Chart ViiV Healthcare Antiretroviral Drug Business Overview
Table ViiV Healthcare Antiretroviral Drug Product Specification
Chart Bristol-Myer Squibb Antiretroviral Drug Shipments, Price, Revenue and Gross profit 2014-2018
Chart Bristol-Myer Squibb Antiretroviral Drug Business Distribution
Chart Bristol-Myer Squibb Interview Record (Partly)
Figure Bristol-Myer Squibb Antiretroviral Drug Product Picture
Chart Bristol-Myer Squibb Antiretroviral Drug Business Overview
Table Bristol-Myer Squibb Antiretroviral Drug Product Specification
3.4 AbbVie Antiretroviral Drug Business Introduction
…
Chart United States Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart United States Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Canada Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Canada Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart South America Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart South America Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart China Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart China Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Japan Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Japan Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart India Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart India Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Korea Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Korea Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Germany Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Germany Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart UK Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart UK Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart France Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart France Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Italy Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Italy Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Europe Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Europe Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Middle East Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Middle East Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Africa Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Africa Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart GCC Antiretroviral Drug Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart GCC Antiretroviral Drug Sales Price ($/Unit) 2014-2018
Chart Global Antiretroviral Drug Market Segmentation (Region Level) Sales Volume 2014-2018
Chart Global Antiretroviral Drug Market Segmentation (Region Level) Market size 2014-2018
Chart Antiretroviral Drug Market Segmentation (Product Type Level) Volume (Units) 2014-2018
Chart Antiretroviral Drug Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018
Chart Different Antiretroviral Drug Product Type Price ($/Unit) 2014-2018
Chart Antiretroviral Drug Market Segmentation (Industry Level) Market Size (Volume) 2014-2018
Chart Antiretroviral Drug Market Segmentation (Industry Level) Market Size (Share) 2014-2018
Chart Antiretroviral Drug Market Segmentation (Industry Level) Market Size (Value) 2014-2018
Chart Global Antiretroviral Drug Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018
Chart Global Antiretroviral Drug Market Segmentation (Channel Level) Share 2014-2018
Chart Antiretroviral Drug Segmentation Market Forecast (Region Level) 2018-2023
Chart Antiretroviral Drug Segmentation Market Forecast (Product Type Level) 2018-2023
Chart Antiretroviral Drug Segmentation Market Forecast (Industry Level) 2018-2023
Chart Antiretroviral Drug Segmentation Market Forecast (Channel Level) 2018-2023
Chart Multi-Class Drugs Combination Product Figure
Chart Multi-Class Drugs Combination Product Advantage and Disadvantage Comparison
Chart NRTI Product Figure
Chart NRTI Product Advantage and Disadvantage Comparison
Chart NNRTI Product Figure
Chart NNRTI Product Advantage and Disadvantage Comparison
Chart Protease Inhibitors Product Figure
Chart Protease Inhibitors Product Advantage and Disadvantage Comparison
Chart Hospital Clients
Chart Pharmaceutical Companies Clients
